Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
MMF
MMRd
molecular pharmacological audit trial (MoPhAT)
monoclonal antibodies (Mabs) Answer 12.1 class and target drug conjugates Monoclonal Antibodies Including Immunoconjugates and Cytokine-Directed Agents Multiple Myeloma as a Paradigm for Multi-Targeted Intervention naked overview prevention and management of infusion-related reactions Question 12.1 radioimmunoconjugates structure and classification uses
monomethyl auristatin E (MMAE)
MoPhAT
MPA
MPN
MRD
MRP
MSI
MTD
mTOR
mTORC1
mTOR complex 1 (mTORC1)
MTX
multidrug resistance (MDR)
multidrug-resistant protein (MRP)
multiple myeloma (MM)
mycophenolate mofetil (MMF)
mycophenolic acid (MPA)
myelodysplastic syndromes (MDSs)
myeloid-derived suppressor cells (MDSCs)
myeloproliferative neoplasms (MPN)
MZL
Naked monoclonal antibodies antibody-drug conjugate (ADC) Monoclonal Antibodies Including Immunoconjugates and Cytokine-Directed Agents
National Comprehensive Cancer Network (NCCN) Answer 3.2 Antimetabolites: Hydroxyurea, Pyrimidine and Purine Analogs, and L-Asparaginase Hormonal Therapies Alone and in Combinations for Treatment of Breast Cancer
natural killer (NK) Monoclonal Antibodies Including Immunoconjugates and Cytokine-Directed Agents Multiple Myeloma as a Paradigm for Multi-Targeted Intervention
NCCN
NDAs